{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:18:09Z","timestamp":1795094289968,"version":"4.10.2"},"reference-count":119,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2556,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1111\/j.1469-0691.2007.01813.x","type":"journal-article","created":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T10:05:58Z","timestamp":1188641158000},"page":"1144-1156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1) \u2013 Report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)"],"prefix":"10.1016","volume":"13","author":[{"given":"F.","family":"Drobniewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"R\u00fcsch-Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hoffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01813.x_bib1","first-page":"213","article-title":"Global tuberculosis incidence and mortality during 1990\u20132000","volume":"72","author":"Dolin","year":"1994","journal-title":"Bull WHO"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.1995.03520270054031","article-title":"Global epidemiology of tuberculosis morbidity and mortality of a world\u2010wide epidemic","volume":"273","author":"Raviglione","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib3","first-page":"419","article-title":"Epidemiology of tuberculosis in the world","volume":"18","author":"Drobniewski","year":"1997","journal-title":"Semin Rep Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement\u2014global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(98)08341-X","article-title":"First\u2010line tuberculosis therapy and drug\u2010resistant Mycobacterium tuberculosis in prisons","volume":"353","author":"Coninx","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib6","first-page":"6","article-title":"Tuberculosis in developing countries: burden, intervention and cost","volume":"65","author":"Murray","year":"1990","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM199302253280801","article-title":"The emergence of drug\u2010resistant tuberculosis in New York City","volume":"328","author":"Frieden","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199507273330406","article-title":"Tuberculosis in New York City\u2014turning the tide","volume":"333","author":"Frieden","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/thx.52.12.1060","article-title":"Tuberculosis in England and Wales in 1993: results of a national survey","volume":"52","author":"Kumar","year":"1997","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib10","first-page":"297","article-title":"Secular trends of tuberculosis in Western Europe","volume":"71","author":"Raviglione","year":"1993","journal-title":"Bull WHO"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.05.00136004","article-title":"Tuberculosis, HIV seroprevalence, and intravenous drug abuse in Russian prisoners","volume":"26","author":"Drobniewski","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1086\/339818","article-title":"Worldwide incidence of multidrug\u2010resistant tuberculosis","volume":"185","author":"Dye","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","article-title":"Global surveillance for anti\u2010tuberculosis drug resistance, 1994\u20131997","volume":"338","author":"Pablos\u2010Mendez","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1056\/NEJM200104263441706","article-title":"Global trends in resistance to antituberculosis drugs","volume":"344","author":"Espinal","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib15","series-title":"Anti\u2010tuberculosis drug resistance in the world. The WHO\/IUATLD Global Project on anti\u2010tuberculosis drug resistance surveillance","author":"World Health Organisation","year":"1997"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib16","series-title":"WHO\/IUATLD Global Project on anti\u2010tuberculosis drug resistance surveillance, Anti\u2010tuberculosis drug resistance in the world: third global report, 1999\u20132002","author":"World Heath Organisation","year":"2004"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug\u2010resistant tuberculosis","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug\u2010resistant tuberculosis as a cause of death in patients co\u2010infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bmj.318.7182.497","article-title":"Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994\u20131996","volume":"318","author":"Irish","year":"1999","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib20","first-page":"170","article-title":"High prevalence of drug\u2010resistant tuberculosis, Republic of Lithuania, 2002","volume":"9","author":"Dewan","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib21","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JCM.39.9.3339-3345.2001","article-title":"Spread of drug\u2010resistant pulmonary tuberculosis in Estonia","volume":"39","author":"Kr\u00fc\u00fcner","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3201\/eid1109.041236","article-title":"Multidrug\u2010resistant tuberculosis detection, Latvia","volume":"11","author":"Skenders","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3201\/eid0811.020507","article-title":"Rifampin\u2010 and multidrug\u2010resistant tuberculosis in Russian civilians and prison inmates: dominance of the Beijing strain family","volume":"8","author":"Drobniewski","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/JCM.40.6.1930-1937.2002","article-title":"Spread of drug\u2010resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia","volume":"40","author":"Toungoussova","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10096-003-0944-0","article-title":"PCR\u2010based methodology for detecting multidrug\u2010resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia","volume":"22","author":"Mokrousov","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thx.2004.026922","article-title":"Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia","volume":"60","author":"Ruddy","year":"2005","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib27","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.293.22.2726","article-title":"Drug resistant tuberculosis, clinical virulence and the dominance of the Beijing strain family in Russia","volume":"293","author":"Drobniewski","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib28","first-page":"646","article-title":"The Beijing genotype is a major cause of drug\u2010resistant tuberculosis in Kazakhstan","volume":"9","author":"Kubica","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib29","first-page":"582","article-title":"Streptomycin in Tuberculous Trials Committee, streptomycin treatment of tuberculous meningitis","volume":"i","author":"Medical Research Council","year":"1948","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0041-3879(62)80066-X","article-title":"Long\u2010term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation","volume":"43","author":"Medical Research Council","year":"1962","journal-title":"Tubercle"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib31","first-page":"1079","article-title":"Controlled clinical trial of short course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis","volume":"ii","author":"East African\/British Medical Research Councils","year":"1972","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib32","first-page":"471","article-title":"Controlled trial of four 6 month regimens of chemotherapy for pulmonary tuberculosis. Second study. Second report","volume":"114","author":"East African\/British Medical Research Council","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/bmj.2.4588.1009","article-title":"Streptomycin resistance in pulmonary tuberculosis","volume":"ii","author":"Crofton","year":"1948","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib34","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short\u2010course chemotherapy for drug resistant tuberculosis: treatment outcome in six countries","volume":"283","author":"Espinal","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATPsynthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin","volume":"328","author":"Goble","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(05)60878-1","article-title":"Is death inevitable with multi\u2010resistant TB plus HIV infection?","volume":"349","author":"Drobniewski","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.301.6749.412","article-title":"Impact of HIV on tuberculosis in Zambia: a cross sectional study","volume":"301","author":"Elliott","year":"1990","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199101313240503","article-title":"Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection","volume":"324","author":"Small","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib40","first-page":"S24","article-title":"Multidrug resistant TB (MDRTB) among AIDS patients in an infectious disease hospital, Buenos Aires","volume":"1","author":"Weinbaum","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib41","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/thorax.57.9.810","article-title":"A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK","volume":"57","author":"Drobniewski","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM199510053331404","article-title":"Multi\u2010drug resistant tuberculosis in patients without HIV infection","volume":"333","author":"Telzak","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib43","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/clinids\/21.5.1238","article-title":"Improved outcomes for patients with multidrug\u2010resistant tuberculosis","volume":"21","author":"Turett","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib44","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/clinids\/21.5.1245","article-title":"Predictors and outcome of multi\u2010drug resistant tuberculosis","volume":"21","author":"Salomon","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1164\/ajrccm.153.1.8542137","article-title":"Outcome of MDRTB patients, 1983\u20131993: prolonged survival with appropriate therapy","volume":"153","author":"Park","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa022928","article-title":"Community\u2010based therapy for multidrug\u2010resistant tuberculosis in Lima, Peru","volume":"348","author":"Mitnick","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM200107193450303","article-title":"The treatment of multidrug\u2010resistant tuberculosis in Turkey","volume":"345","author":"Tahaoglu","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib48","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0140-6736(02)08830-X","article-title":"Feasibility and cost\u2010effectiveness of standardised second\u2010line drug treatment for chronic tuberculosis patients: a national cohort study in Peru","volume":"359","author":"Suarez","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib49","first-page":"231","article-title":"Quality assurance programme for drug susceptibility testing of mycobacterium tuberculosis in the WHO\/IUATLD Supranational Laboratory Network: first round of proficiency testing","volume":"1","author":"Laszlo","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/thorax.57.6.477","article-title":"Antibiotic resistant tuberculosis in the United Kingdom; 1993\u20131999","volume":"57","author":"Djuretic","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/am.20.5.810-814.1970","article-title":"Probability distribution of drug resistant mutants in unselected populations of Mycobacterium tuberculosis","volume":"20","author":"David","year":"1970","journal-title":"Appl Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1993.03510010071032","article-title":"Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance","volume":"270","author":"Mahmoudi","year":"1993","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib53","first-page":"565","article-title":"Mycobacteria: laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti","year":"1963","journal-title":"Bull WHO"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib54","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull WHO"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib55","series-title":"Public health mycobacteriology. A guide for the level III laboratory","author":"Kent","year":"1985"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib56","series-title":"Antimycobacterial susceptibility testing for Mycobacterium tuberculosis","author":"National Committee for Clinical Laboratory Standards","year":"1995"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib57","series-title":"Clinics in laboratory medicine","first-page":"641","article-title":"Drug susceptibility testing","author":"Heifets","year":"1996"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib58","series-title":"Guidelines for surveillance of drug resistance in tuberculosis","author":"World Health Organisation","year":"2001"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib59","series-title":"Guidelines for drug susceptibility testing of second line drugs for Mycobacterium tuberculosis","author":"World Health Organisation","year":"2001"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0962-8479(94)90096-5","article-title":"Drug\u2010resistant tuberculosis: laboratory issues","volume":"75","author":"Vareldzis","year":"1994","journal-title":"Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib61","first-page":"1066","article-title":"Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media","volume":"115","author":"Middlebrook","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/jcm.18.3.689-696.1983","article-title":"Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid\u2010fast smear positive specimens","volume":"18","author":"Roberts","year":"1983","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib63","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/jcm.34.6.1565-1567.1996","article-title":"Testing of Mycobacterium tuberculosis to isoniazid and rifampicin by Mycobacterium Growth Indicator Tube Method","volume":"34","author":"Walters","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/jcm.35.2.364-368.1997","article-title":"Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid fast bacilli","volume":"35","author":"Pfyffer","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0732-8893(95)00147-7","article-title":"Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampicin","volume":"22","author":"Resiner","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib66","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JCM.42.3.1109-1114.2004","article-title":"Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method","volume":"42","author":"Scarparo","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.40.2.607-610.2002","article-title":"Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion","volume":"40","author":"Tortoli","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib68","first-page":"142","article-title":"Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first\u2010line drugs: comparisons of the MGIT 960 and BACTEC 460 systems","volume":"32","author":"Huang","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib69","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/JCM.41.3.1235-1239.2003","article-title":"Susceptibility testing with the manual mycobacterium growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug\u2010resistant tuberculosis","volume":"41","author":"Adjers\u2010Koskela","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib70","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/JCM.39.12.4440-4444.2001","article-title":"Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis","volume":"39","author":"Ardito","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.40.1.150-154.2002","article-title":"Multicenter evaluation of fully automated BACTEC mycobacterium growth indicator tube 960 system for susceptibility testing of Mycobacterium tuberculosis","volume":"40","author":"Bemer","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib72","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Critical concentration setting and evaluation of MGIT 960 antimicrobial susceptibility testing to first\u2010 and second\u2010line antimicrobial drugs with clinical drug\u2010resistant strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib73","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/JCM.38.5.1988-1989.2000","article-title":"Evaluation of the MB\/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis","volume":"38","author":"Diaz\u2010Infantes","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib74","first-page":"1157","article-title":"Is second\u2010line anti\u2010tuberculosis drug susceptibility testing reliable?","volume":"8","author":"Kim","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib75","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second\u2010line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","article-title":"Multicenter laboratory validation of drug susceptibility testing of Mycobacterium tuberculosis against classical second\u2010line drugs and newer antimicrobials by the BACTEC MGIT 960 technique","volume":"44","author":"R\u00fcsch\u2010Gerdes","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib77","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/JCM.42.11.5225-5228.2004","article-title":"Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin","volume":"42","author":"Sanders","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/rccm.200411-1557OC","article-title":"The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis","volume":"172","author":"Sirgel","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkg345","article-title":"A multicentre comparison of a novel surrogate marker for determining the specific potency of anti\u2010tuberculosis drugs","volume":"52","author":"Gosling","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.47.2.653-657.2003","article-title":"Sterilizing activities of fluoroquinolones against rifampin\u2010tolerant populations of Mycobacterium tuberculosis","volume":"47","author":"Hu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib81","first-page":"899","article-title":"Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic\u2010Baltic collaboration","volume":"7","author":"Johansen","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"InhA, a gene encoding a target for isoniazide and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib83","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","article-title":"Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot","volume":"9","author":"Finken","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(94)91338-2","article-title":"Implications of multi\u2010drug resistance for the future of short course chemotherapy of tuberculosis: a molecular study","volume":"344","author":"Heym","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2958.1995.tb02238.x","article-title":"Missense mutations in the catalase\u2010peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"15","author":"Heym","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib86","first-page":"138","article-title":"Rapid Mycobacterium species assignments and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing","volume":"119","author":"Kapur","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib87","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase\u2010peroxidase gene and isoniazid resistance to Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","article-title":"Detection of rifampicin\u2010resistance mutations in Mycobacterium tuberculosis","volume":"341","author":"Telenti","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib90","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.38.10.2380","article-title":"Characterisation of rifampicin resistance in pathogenic mycobacteria","volume":"38","author":"Williams","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib91","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3201\/eid1009.040046","article-title":"Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis","volume":"10","author":"Baker","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib92","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1469-0691.2004.01034.x","article-title":"Single\u2010nucleotide polymorphism\u2010based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum","volume":"11","author":"Arnold","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib93","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0924-8579(03)00036-0","article-title":"Molecular analysis of rifampicin\u2010resistant Mycobacterium tuberculosis isolated in Spain (1996\u20132001). Description of new mutations in the rpoB gene and review of the literature","volume":"21","author":"Herrera","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/JCM.39.1.107-110.2001","article-title":"Frequency of rpoB mutations inside and outside the cluster I region in rifampin\u2010resistant clinical Mycobacterium tuberculosis isolates","volume":"39","author":"Heep","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib95","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/JCM.41.7.2822-2826.2003","article-title":"Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system","volume":"41","author":"Somoskovi","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib96","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1128\/AAC.49.6.2218-2225.2005","article-title":"Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol","volume":"49","author":"Parsons","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib97","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/AAC.49.4.1455-1464.2005","article-title":"A molecular analysis of isoniazid resistant Mycobacterium tuberculosis isolates in England and Wales","volume":"49","author":"Baker","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib98","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1101\/gr.8.5.435","article-title":"Simultaneous genotyping and species identification using hybridisation pattern recognition analysis of generic Mycobacterium DNA arrays","volume":"8","author":"Gingeras","year":"1998","journal-title":"Genome Res"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib99","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1073\/pnas.86.16.6230","article-title":"Genetic analysis of amplified DNA with immobilized sequence specific oligonucleotide probes","volume":"86","author":"Saiki","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib100","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1128\/JCM.36.7.1969-1973.1998","article-title":"Comparison of three molecular assays for rapid detection of rifampicin resistance in Mycobacterium tuberculosis","volume":"36","author":"Watterson","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib101","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0962-8479(95)90009-8","article-title":"Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay","volume":"76","author":"De Beenhouwer","year":"1995","journal-title":"Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib102","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1099\/0022-1317-49-3-271","article-title":"A clinical, microbiological and economic analysis of a national UK service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis","volume":"49","author":"Drobniewski","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0923-2508(02)01311-6","article-title":"Molecular characterization of multiple\u2010drug\u2010resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA\/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene","volume":"153","author":"Mokrousov","year":"2002","journal-title":"Res Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib104","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JCM.42.10.4498-4502.2004","article-title":"Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation","volume":"42","author":"Nikolayevsky","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.mimet.2005.08.002","article-title":"The use of macroarrays for the identification of MDR Mycobacterium tuberculosis","volume":"65","author":"Brown","year":"2005","journal-title":"J Microbiol Meth"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/JCM.37.1.49-55.1999","article-title":"Mycobacterium species identification and rifampin resistance testing with high\u2010density DNA probe arrays","volume":"37","author":"Troesch","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib107","first-page":"21","article-title":"Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis","volume":"6","author":"Vasil'eva","year":"2002","journal-title":"Probl Tuberk"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/JCM.37.2.290-295.1999","article-title":"Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis","volume":"37","author":"Hellyer","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib109","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/JCM.37.11.3524-3527.1999","article-title":"Evaluation of reverse transcription\u2010PCR and a bacteriophage\u2010based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis","volume":"37","author":"Eltringham","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib110","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/JCM.39.11.4131-4137.2001","article-title":"Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons","volume":"39","author":"El\u2010Hajj","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib111","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nbt0498-359","article-title":"Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis","volume":"16","author":"Piatek","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.44.1.103-110.2000","article-title":"Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing","volume":"44","author":"Piatek","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib113","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.8484123","article-title":"Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages","volume":"260","author":"Jacobs","year":"1993","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib114","first-page":"431","article-title":"The use of luciferase\u2010reporter phage for antibiotic\u2010susceptibility testing in mycobacteria","volume":"101","author":"Riska","year":"1998","journal-title":"Meth Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm0497-465","article-title":"Evaluation of a new rapid bacteriophage\u2010based method for the drug susceptibility testing of Mycobacterium tuberculosis","volume":"3","author":"Wilson","year":"1997","journal-title":"Nature Med"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib116","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/JCM.37.11.3524-3527.1999","article-title":"Evaluation of reverse transcription\u2010PCR and a bacteriophage\u2010based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis","volume":"37","author":"Eltringham","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib117","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5588\/09640569513048","article-title":"Rapid indication of multidrug\u2010resistant tuberculosis from liquid cultures using FASTPlaque TB\u2010RIF, a manual phage\u2010based test","volume":"6","author":"Albert","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/JCM.36.5.1214-1219.1998","article-title":"Use of 3\u2010(4,5\u2010dimethylthiazol\u20102\u2010yl)\u20102,5\u2010diphenyl tetrazolium bromide for rapid detection of rifampicin\u2010resistant Mycobacterium tuberculosis","volume":"36","author":"Mshana","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01813.x_bib119","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1469-0691.2007.01698.x","article-title":"Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods","volume":"13","author":"Palomino","year":"2007","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14625817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14625817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:25:38Z","timestamp":1795091138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14625817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1198743X14625817"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01813.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1) \u2013 Report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01813.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}